PROGRAM

TCT 2019 will feature a host of sponsored satellite programs offering attendees comprehensive insights into important interventional topics and issues facing interventional specialists. 

Sponsored sessions include breakfast programs, lunchtime Presentation Theater programs, and evening programming. 

Pre-Registration for Satellite Programs

Pre-registration does not guarantee a seat in the program. On-site attendance to each satellite program will be granted on a first-come, first-served basis. Due to limited seating, all interested attendees are strongly encouraged to show up at least 15 minutes prior to the start of each program.

Already Registered for TCT? Click Here!
Log back in to your TCT Registration (Registration Resource Center) to select your satellite programs. Once logged into the Registration Resource Center, click Home and then Upgrade.

New TCT Registrants? Click Here!
Sign up for TCT and register for satellite programs.

Note: Advance registration for satellite programs is not available to industry professionals. Industry professionals may register for satellite programs on-site on a first-come, first-served basis.

Satellite Programs

Expanding Applications for Intravenous Platelet Inhibition

Evening Program

09/27/2019 18:30:00 09/27/2019 20:00:00 Expanding Applications for Intravenous Platelet Inhibition TCT 2017 true MM/DD/YYYY TCT 2014 Satellite Symposia - Evening Program

Friday, September 27, 2019
Reception: 6:00 pm  | 
Program: 6:30 pm-8:00 pm
San Francisco Marriott Marquis, Yerba Buena Ballroom 7, Lower B2 Level

Expanding Applications for Intravenous Platelet Inhibition

Expanding Applications for Intravenous Platelet Inhibition

Sponsored by Cardiovascular Research Foundation

Supported through an educational grant from Chiesi USA, Inc.

The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cardiovascular Research Foundation designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Chairs  

Deepak L. Bhatt, MD, MPH

Brigham and Women's Hospital

Boston, MA

 

Gregg W. Stone, MD

NewYork-Presbyterian/ Columbia University Medical Center

New York, NY

Faculty  

Dominick J. Angiolillo, MD, PhD

University of Florida

Jacksonville, FL

 

Francesco Franchi, MD, ChB, MD

University of Florida

Jacksonville, FL

 

C. Michael Gibson, MS, MD

Dominick J. Angiolillo, MD, PhD University of Florida Jacksonville, FL Francesco Franchi, MB, ChB, MD University of Florida Jacksonville, FL C. Michael Gibson, MS, MD Beth Israel Deaconess Medical Center Boston, MA Roxana Mehran, MD Icahn School of Medi

Boston, MA

 

Roxana Mehran, MD

Icahn School of Medicine at Mount Sinai

New York, NY

Agenda

6:30 pm

Which Patients Are (and Are Not) Candidates for Intravenous Platelet Inhibition During PCI?

Gregg W. Stone

6:40 pm

Roundtable Discussion With Audience Q&A

6:43 pm

Intravenous Platelet Inhibition for PCI: Drug Description and Clinical Outcomes From Randomized Trials and Registries

Deepak L. Bhatt

6:58 pm

Roundtable Discussion With Audience Q&A

7:03 pm

Intravenous Platelet Inhibition for PCI and Bridging: Duration, Oral Drug Conversion and More

Dominick J. Angiolillo

7:15 pm

Roundtable Discussion With Audience Q&A

7:19 pm

Case #1 Introduction: PCI in a Patient With ACS

C. Michael Gibson

7:22 pm

Roundtable Discussion: How Should We Treat This Patient?

7:27 pm

Case #1 Resolution: How Did We Treat This Patient? What Might We Have Done Differently

C. Michael Gibson

7:32 pm

Case #2 Introduction: Intravenous Platelet Inhibition During PCI in Complex Stable CAD

Francesco Franchi

7:35 pm

Roundtable Discussion: How Should We Treat This Patient?

7:40 pm

Case #2 Resolution: How Did We Treat This Patient? What Might We Have Done Differently

Francesco Franchi

7:45 pm

Case #3 Introduction: A Case in Which We Might Consider Bridging

Roxana Mehran

7:48 pm

Roundtable Discussion: How Should We Treat This Patient?

7:53 pm

Case #3 Resolution: How Did We Treat This Patient? What Might We Have Done Differently

Roxana Mehran

7:58 pm

Take-home Messages: The Expanding Role of Intravenous Platelet Inhibition for PCI

Gregg W. Stone

8:00 pm

Adjourn

8:01 pm

Adjourn